Merck
MRK
#54
Rank
NZ$469.71 B
Marketcap
NZ$190.18
Share price
2.73%
Change (1 day)
37.32%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): NZ$12.54

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$12.40. an increase over its 2024 EPS that were of NZ$11.46.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025NZ$12.347.71%
2024NZ$11.464308.46%
2023NZ$0.26-97.32%
2022NZ$9.7210.92%
2021NZ$8.7684.68%
2020NZ$4.74-27.2%
2019NZ$6.5163.44%
2018NZ$3.99151.11%
2017NZ$1.59-54.58%
2016NZ$3.4930.21%
2015NZ$2.68-61.99%
2014NZ$7.06180.51%
2013NZ$2.52-31.82%
2012NZ$3.696.62%
2011NZ$3.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.89 52.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.21-1.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.36-48.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.04 214.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.30 96.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.50-71.75%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$5.87-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.39-48.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.10-83.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel